{"transactions":[{"id":702042,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-07-28T21:37:04.000Z","date":"2026-07-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12003,"price":25,"value":300075.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12003},"source":{"system":"sec-edgar","filing":"0001606498-26-000107","document":"wk-form4_1785274622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000107/wk-form4_1785274622.xml","form_type":"4"}},{"id":702041,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-28T21:37:04.000Z","date":"2026-07-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4817,"price":25,"value":120425.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001606498-26-000107","document":"wk-form4_1785274622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000107/wk-form4_1785274622.xml","form_type":"4"}},{"id":781964,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-05-12T15:40:30.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":12003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors."}],"balance_after":12003,"derivative":{"underlying":"Common Stock","underlying_shares":12003},"source":{"system":"sec-edgar","filing":"0001606498-26-000075","document":"wk-form4_1778600427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000075/wk-form4_1778600427.xml","form_type":"4"}},{"id":1309715,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T18:49:58.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":12003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the Reporting Person on January 2, 2025 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan."}],"balance_after":16820,"source":{"system":"sec-edgar","filing":"0001606498-25-000012","document":"wk-form4_1736189392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000012/wk-form4_1736189392.xml","form_type":"4"}},{"id":1610408,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-02-29T21:16:50.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":false,"shares":878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On February 27, 2023, the reporting person was granted 2,632 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date.  On February 27, 2024, the first tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4."}],"balance_after":1754,"derivative":{"expiration_date":"2026-02-27","underlying":"Common Stock","underlying_shares":878},"source":{"system":"sec-edgar","filing":"0001735276-24-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000016/edgardoc.xml","form_type":"4"}},{"id":1610407,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-29T21:16:50.000Z","date":"2024-02-28","kind":"sale","planned":false,"acquired":false,"shares":1,"price":158.09,"value":158.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."}],"balance_after":4133,"source":{"system":"sec-edgar","filing":"0001735276-24-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000016/edgardoc.xml","form_type":"4"}},{"id":1610406,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-29T21:16:50.000Z","date":"2024-02-28","kind":"sale","planned":false,"acquired":false,"shares":9,"price":157.3,"value":1415.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $157.01 to $157.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4134,"source":{"system":"sec-edgar","filing":"0001735276-24-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000016/edgardoc.xml","form_type":"4"}},{"id":1610405,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-29T21:16:50.000Z","date":"2024-02-28","kind":"sale","planned":false,"acquired":false,"shares":66,"price":156.38,"value":10321.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $155.96 to $156.91. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4143,"source":{"system":"sec-edgar","filing":"0001735276-24-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000016/edgardoc.xml","form_type":"4"}},{"id":1610404,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-29T21:16:50.000Z","date":"2024-02-28","kind":"sale","planned":false,"acquired":false,"shares":111,"price":155.45,"value":17254.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $154.95 to $155.95. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4209,"source":{"system":"sec-edgar","filing":"0001735276-24-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000016/edgardoc.xml","form_type":"4"}},{"id":1610403,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-29T21:16:50.000Z","date":"2024-02-28","kind":"sale","planned":false,"acquired":false,"shares":142,"price":154.54,"value":21944.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $153.94 to $154.94. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4320,"source":{"system":"sec-edgar","filing":"0001735276-24-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000016/edgardoc.xml","form_type":"4"}},{"id":1610402,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-29T21:16:50.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":true,"shares":878,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4462,"source":{"system":"sec-edgar","filing":"0001735276-24-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000016/edgardoc.xml","form_type":"4"}},{"id":1659413,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-02-05T21:05:23.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":5175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date.  On February 1, 2024, the second tranche of restricted stock units from the February 1, 2022 grant vested and was released, as reported on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date.  On February 1, 2024, the second tranche of restricted stock units from the February 1, 2022 grant vested and was released, as reported on this Form 4."}],"balance_after":5175,"derivative":{"underlying":"Common Stock","underlying_shares":5175},"source":{"system":"sec-edgar","filing":"0001735276-24-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000002/edgardoc.xml","form_type":"4"}},{"id":1659412,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-05T21:05:23.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":269,"price":172.38,"value":46370.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $171.80 to $172.60. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":3584,"source":{"system":"sec-edgar","filing":"0001735276-24-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000002/edgardoc.xml","form_type":"4"}},{"id":1659411,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-05T21:05:23.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":820,"price":171.14,"value":140334.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $170.58 to $171.54. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":3853,"source":{"system":"sec-edgar","filing":"0001735276-24-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000002/edgardoc.xml","form_type":"4"}},{"id":1659410,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-05T21:05:23.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":502,"price":170.01,"value":85345.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $169.57 to $170.57. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4673,"source":{"system":"sec-edgar","filing":"0001735276-24-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000002/edgardoc.xml","form_type":"4"}},{"id":1659409,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2024-02-05T21:05:23.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":5175,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5175,"source":{"system":"sec-edgar","filing":"0001735276-24-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000002/edgardoc.xml","form_type":"4"}},{"id":1922386,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2023-04-10T20:29:17.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":3500,"price":210,"value":735000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-23-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000038/edgardoc.xml","form_type":"4"}},{"id":1984081,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Stock Option  (right to buy)","published_at":"2023-03-01T21:21:07.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":5449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date."}],"balance_after":5449,"derivative":{"exercise_price":190.01,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":5449},"source":{"system":"sec-edgar","filing":"0001735276-23-000026","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000026/edgardoc.xml","form_type":"4"}},{"id":1984080,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-03-01T21:21:07.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":2632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance.  The reporting person also received 5,263 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date."}],"balance_after":2632,"derivative":{"expiration_date":"2026-02-27","underlying":"Common Stock","underlying_shares":2632},"source":{"system":"sec-edgar","filing":"0001735276-23-000026","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000026/edgardoc.xml","form_type":"4"}},{"id":2033560,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-02-03T22:46:11.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":5175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date.  On February 1, 2023 the first third vested and released as reported on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date.  On February 1, 2023 the first third vested and released as reported on this Form 4."}],"balance_after":10350,"derivative":{"underlying":"Common Stock","underlying_shares":5175},"source":{"system":"sec-edgar","filing":"0001735276-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000007/edgardoc.xml","form_type":"4"}},{"id":2033559,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:11.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":5,"price":227.38,"value":1136.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001735276-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000007/edgardoc.xml","form_type":"4"}},{"id":2033558,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:11.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":586,"price":226.62,"value":132799.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.23 to $227.12. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":3505,"source":{"system":"sec-edgar","filing":"0001735276-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000007/edgardoc.xml","form_type":"4"}},{"id":2033557,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:11.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":1007,"price":225.8,"value":227380.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $225.21 to $226.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4091,"source":{"system":"sec-edgar","filing":"0001735276-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000007/edgardoc.xml","form_type":"4"}},{"id":2033556,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:11.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":77,"price":223.97,"value":17245.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.42 to $224.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":5098,"source":{"system":"sec-edgar","filing":"0001735276-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000007/edgardoc.xml","form_type":"4"}},{"id":2033555,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:11.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":5175,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5175,"source":{"system":"sec-edgar","filing":"0001735276-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000007/edgardoc.xml","form_type":"4"}},{"id":2406641,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Stock Option  (right to buy)","published_at":"2022-02-10T01:59:08.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":29182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter."}],"balance_after":29182,"derivative":{"exercise_price":144.93,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":29182},"source":{"system":"sec-edgar","filing":"0001735276-22-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000012/edgardoc.xml","form_type":"4"}},{"id":2406640,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO & Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-02-10T01:59:08.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":15525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest ratably on each of the first, second and third anniversaries of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest ratably on each of the first, second and third anniversaries of the Grant Date."}],"balance_after":15525,"derivative":{"underlying":"Common Stock","underlying_shares":15525},"source":{"system":"sec-edgar","filing":"0001735276-22-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000012/edgardoc.xml","form_type":"4"}},{"id":2626545,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-07-23T16:37:55.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":25165,"price":100.14,"value":2520023.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the First Effective Time, these options were cancelled and converted into the right to receive the product obtained by multiplying (A) the excess, if any, of the value of the Merger Consideration over the exercise price per share of the Alexion common stock subject to such options immediately prior to the First Effective Time by (B) the number of shares of Alexion common stock subject to such option immediately prior to the First Effective Time by (ii) the value of the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":100.14,"exercise_date":"2018-06-07","expiration_date":"2027-06-07","underlying":"Common Stock, par value $.0001 per share","underlying_shares":25165},"source":{"system":"sec-edgar","filing":"0000899866-21-000066","document":"wf-form4_162707265918164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000066/wf-form4_162707265918164.xml","form_type":"4"}},{"id":2626544,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-23T16:37:55.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":116075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC.  In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899866-21-000066","document":"wf-form4_162707265918164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000066/wf-form4_162707265918164.xml","form_type":"4"}},{"id":2632536,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:53:12.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":25813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan."}],"balance_after":116075,"source":{"system":"sec-edgar","filing":"0000899866-21-000056","document":"wf-form4_162646878098060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000056/wf-form4_162646878098060.xml","form_type":"4"}},{"id":2632535,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-16T16:53:12.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":26812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied.  These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan."}],"balance_after":90262,"source":{"system":"sec-edgar","filing":"0000899866-21-000056","document":"wf-form4_162646878098060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000056/wf-form4_162646878098060.xml","form_type":"4"}},{"id":2676494,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-06-09T16:50:22.000Z","date":"2021-06-08","kind":"tax_withholding","acquired":false,"shares":928,"price":177,"value":164256.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":63450,"source":{"system":"sec-edgar","filing":"0000899866-21-000048","document":"wf-form4_162327180875734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000048/wf-form4_162327180875734.xml","form_type":"4"}},{"id":2822831,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-03-02T17:54:39.000Z","date":"2021-02-28","kind":"grant","acquired":true,"shares":18033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":64378,"source":{"system":"sec-edgar","filing":"0000899866-21-000025","document":"wf-form4_161472565376598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000025/wf-form4_161472565376598.xml","form_type":"4"}},{"id":2938552,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:08:14.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":2913,"price":157.96,"value":460137.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":46345,"source":{"system":"sec-edgar","filing":"0000899866-20-000094","document":"wf-form4_160832927928084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000094/wf-form4_160832927928084.xml","form_type":"4"}},{"id":2938551,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:08:14.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":16925,"price":157.96,"value":2673473.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."}],"balance_after":49258,"source":{"system":"sec-edgar","filing":"0000899866-20-000094","document":"wf-form4_160832927928084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000094/wf-form4_160832927928084.xml","form_type":"4"}},{"id":2938550,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-12-18T17:08:14.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":37965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan."}],"balance_after":66183,"source":{"system":"sec-edgar","filing":"0000899866-20-000094","document":"wf-form4_160832927928084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000094/wf-form4_160832927928084.xml","form_type":"4"}},{"id":3117538,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-06-09T17:05:33.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":1433,"price":115,"value":164795.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":28218,"source":{"system":"sec-edgar","filing":"0000899866-20-000065","document":"wf-form4_159173671433425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000065/wf-form4_159173671433425.xml","form_type":"4"}},{"id":3117537,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-06-09T17:05:33.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":5420,"price":114.61,"value":621186.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":29651,"source":{"system":"sec-edgar","filing":"0000899866-20-000065","document":"wf-form4_159173671433425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000065/wf-form4_159173671433425.xml","form_type":"4"}},{"id":3117536,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-06-09T17:05:33.000Z","date":"2020-06-08","kind":"tax_withholding","acquired":false,"shares":1403,"price":114.61,"value":160797.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":35071,"source":{"system":"sec-edgar","filing":"0000899866-20-000065","document":"wf-form4_159173671433425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000065/wf-form4_159173671433425.xml","form_type":"4"}},{"id":3234892,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:16:58.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":1267,"price":90.54,"value":114714.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.48 - $92.39.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":36474,"source":{"system":"sec-edgar","filing":"0000899866-20-000018","document":"wf-form4_158327740132826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000018/wf-form4_158327740132826.xml","form_type":"4"}},{"id":3234891,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-03-03T18:16:58.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":9520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":37741,"source":{"system":"sec-edgar","filing":"0000899866-20-000018","document":"wf-form4_158327740132826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000018/wf-form4_158327740132826.xml","form_type":"4"}},{"id":3283217,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-02-10T16:57:41.000Z","date":"2020-02-07","kind":"tax_withholding","acquired":false,"shares":1406,"price":102.97,"value":144775.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $102.97 - $103.24.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":28221,"source":{"system":"sec-edgar","filing":"0000899866-20-000014","document":"wf-form4_158137184419381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000014/wf-form4_158137184419381.xml","form_type":"4"}},{"id":3472631,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-07-02T16:41:00.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":4500,"price":132.78,"value":597510.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."}],"balance_after":29627,"source":{"system":"sec-edgar","filing":"0000899866-19-000079","document":"wf-form4_156210004597380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000079/wf-form4_156210004597380.xml","form_type":"4"}},{"id":3494875,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-06-11T18:35:35.000Z","date":"2019-06-07","kind":"tax_withholding","acquired":false,"shares":1404,"price":118.61,"value":166528.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":34127,"source":{"system":"sec-edgar","filing":"0000899866-19-000074","document":"wf-form4_156029251991291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000074/wf-form4_156029251991291.xml","form_type":"4"}},{"id":3615636,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-05T20:21:20.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":35531,"source":{"system":"sec-edgar","filing":"0000899866-19-000050","document":"wf-form4_155183526477412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000050/wf-form4_155183526477412.xml","form_type":"4"}},{"id":3620727,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-03-04T17:35:11.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":625,"price":132.93,"value":83081.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.90- $135.01.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":27281,"source":{"system":"sec-edgar","filing":"0000899866-19-000036","document":"wf-form4_155173889807803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000036/wf-form4_155173889807803.xml","form_type":"4"}},{"id":3666573,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-02-11T18:18:48.000Z","date":"2019-02-07","kind":"tax_withholding","acquired":false,"shares":1398,"price":119.57,"value":167158.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $119.43 - $119.57.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":27906,"source":{"system":"sec-edgar","filing":"0000899866-19-000011","document":"wf-form4_154992711355552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000011/wf-form4_154992711355552.xml","form_type":"4"}},{"id":3748102,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-11-30T18:15:40.000Z","date":"2018-11-28","kind":"sale","acquired":false,"shares":2605,"price":118.13,"value":307728.65,"ownership":{"direct":true},"balance_after":29304,"source":{"system":"sec-edgar","filing":"0000899866-18-000135","document":"wf-form4_154361972463867.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000135/wf-form4_154361972463867.xml","form_type":"4"}},{"id":3897514,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-06-12T16:52:08.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":1466,"price":118.53,"value":173764.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":31909,"source":{"system":"sec-edgar","filing":"0000899866-18-000104","document":"wf-form4_152883671232830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000104/wf-form4_152883671232830.xml","form_type":"4"}},{"id":4021796,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-02T17:01:04.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":8344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":33375,"source":{"system":"sec-edgar","filing":"0000899866-18-000060","document":"wf-form4_152002804041916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000060/wf-form4_152002804041916.xml","form_type":"4"}},{"id":4071049,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:16:58.000Z","date":"2018-02-08","kind":"sale","acquired":false,"shares":1459,"price":116.31,"value":169696.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $116.00 - $116.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":25031,"source":{"system":"sec-edgar","filing":"0000899866-18-000039","document":"wf-form4_151813540482732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000039/wf-form4_151813540482732.xml","form_type":"4"}},{"id":4071048,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:16:58.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":13908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 13,908 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 6, 2018 and 1/3 vest on each subsequent anniversary"}],"balance_after":26490,"source":{"system":"sec-edgar","filing":"0000899866-18-000039","document":"wf-form4_151813540482732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000039/wf-form4_151813540482732.xml","form_type":"4"}},{"id":4287610,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-09T18:35:11.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":25165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Stock Options under the 2017 Incentive Plan.  25% vest on the 1-year anniversary of the grant date, and 1/16 vest every 90 days thereafter."}],"balance_after":25165,"derivative":{"exercise_price":100.14,"exercise_date":"2018-06-07","expiration_date":"2027-06-07","underlying":"Common Stock, par value $.0001 per share","underlying_shares":25165},"source":{"system":"sec-edgar","filing":"0000899866-17-000135","document":"wf-form4_149704769575552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000135/wf-form4_149704769575552.xml","form_type":"4"}},{"id":4287609,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":28190,"kind":"person","name":"Franchini Indrani Lall","position":1,"cik":"0001708764","reported_name":"Franchini Indrani Lall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Compliance Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-06-09T18:35:11.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":12582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan.  25% vest on each anniversary of the grant date."}],"balance_after":12582,"source":{"system":"sec-edgar","filing":"0000899866-17-000135","document":"wf-form4_149704769575552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000135/wf-form4_149704769575552.xml","form_type":"4"}}]}